# OnCo record crs-grading-and-management (protocol). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/protocols/crs-grading-and-management/>
  a schema:MedicalGuideline ;
  onco:kind "protocol" ;
  schema:identifier "crs-grading-and-management" ;
  schema:name "Cytokine release syndrome after CAR T-cell therapy: ASTCT grading, tocilizumab and steroids"@en ;
  schema:alternateName "CRS management"@en, "cytokine release syndrome grading"@en, "ASTCT CRS grading"@en, "tocilizumab for CRS"@en, "CAR-T fever"@en ;
  schema:description "After CAR T-cell therapy, the immune cells can release a flood of chemical messengers, causing fever, low blood pressure and breathing trouble: cytokine release syndrome. Any fever after CAR T-cell therapy needs the treating centre at once. Teams grade it from 1 to 4 and treat with tocilizumab and, if needed, steroids; infection is treated at the same time because the two look alike."@en ;
  schema:url <https://onco.cc/protocols/crs-grading-and-management/> ;
  schema:dateModified "2026-11-11"^^xsd:date ;
  onco:tag "protocol", "cell-therapy", "car-t", "acute-oncology" ;
  onco:related <https://onco.cc/protocols/febrile-neutropenia-first-hour/> ;
  onco:technologies <https://onco.cc/technologies/car-t/> ;
  onco:drugs <https://onco.cc/drugs/tocilizumab/>, <https://onco.cc/drugs/siltuximab/>, <https://onco.cc/drugs/dexamethasone/>, <https://onco.cc/drugs/axicabtagene-ciloleucel/>, <https://onco.cc/drugs/tisagenlecleucel/>, <https://onco.cc/drugs/lisocabtagene-maraleucel/>, <https://onco.cc/drugs/brexucabtagene-autoleucel/>, <https://onco.cc/drugs/idecabtagene-vicleucel/>, <https://onco.cc/drugs/ciltacabtagene-autoleucel/>, <https://onco.cc/drugs/obecabtagene-autoleucel/>, <https://onco.cc/drugs/methylprednisolone/> ;
  onco:institutions <https://onco.cc/institutions/sitc/> ;
  onco:terms <https://onco.cc/terms/crs/>, <https://onco.cc/terms/lymphoma-tx-crs-icans/> .
